Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity (2022)
- Authors:
- USP affiliated authors: TROSSINI, GUSTAVO HENRIQUE GOULART - FCF ; HASSANIE, HAIFA - FCF
- Unidade: FCF
- DOI: 10.1038/s41598-022-25534-2
- Subjects: NEOPLASIAS CEREBRAIS; QUIMIOTERAPIA; RADIOTERAPIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Scientific Reports
- ISSN: 2045-2322
- Volume/Número/Paginação/Ano: v. 12, p. 1-17, art. 21113, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
RODRIGUES JUNIOR, Dorival Mendes et al. Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity. Scientific Reports, v. 12, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-25534-2. Acesso em: 27 dez. 2025. -
APA
Rodrigues Junior, D. M., Raminelli, C., Hassanie, H., Trossini, G. H. G., Perecim, G. P., Puigsubira, L. C., et al. (2022). Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity. Scientific Reports, 12, 1-17. doi:10.1038/s41598-022-25534-2 -
NLM
Rodrigues Junior DM, Raminelli C, Hassanie H, Trossini GHG, Perecim GP, Puigsubira LC, Moustakas A, Vettore AL. Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity [Internet]. Scientific Reports. 2022 ; 12 1-17.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1038/s41598-022-25534-2 -
Vancouver
Rodrigues Junior DM, Raminelli C, Hassanie H, Trossini GHG, Perecim GP, Puigsubira LC, Moustakas A, Vettore AL. Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity [Internet]. Scientific Reports. 2022 ; 12 1-17.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1038/s41598-022-25534-2 - Docking studies of the Cannabinoids derivatives in O- GlcNAc Transferase (OGT) as anti-cancer candidates
- Human sirtuin 2 inhibitors, their mechanisms and binding modes
- SETDB1: an emerging target for anticancer drug development [Editorial]
- Synthesis of inhibitors of sirtuin 2 for chagas disease
- Synthesis, molecular modeling and docking studies of nitrofurazone analogues as trypanomicine candidates
- Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides
- Building and validation of a pharmacophore model of LSD-1 inhibitors for virtual screening
- Quantitative structure-activity relationships (HQSAR, CoMFA and CoMSIA) studies for a COX-2 selective inhibitors
- Construction and validation of the CPB2.8 model and pharmacophore model design of cysteine proteases
- An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors
Informações sobre o DOI: 10.1038/s41598-022-25534-2 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3114039.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
